St. Luke’s Regional Cancer Center welcomes Radiation Oncologist Dr.
Nils Arvold. Dr. Arvold joins Dr. Steven Bonin as a member of St. Luke’s
Radiation Oncology Associates.
A Duluth native, Dr. Arvold received his medical degree from Harvard Medical
School, Boston, Massachusetts. He completed his internship in internal
medicine at Massachusetts General Hospital, followed by his radiation
oncology residency in the Harvard Radiation Oncology Program. Dr. Arvold
is board certified in radiation oncology.
Prior to joining St. Luke’s, Dr. Arvold practiced in Boston at Brigham
and Women’s Hospital, Dana-Farber Cancer Institute and Children’s
Hospital Boston. He was an assistant professor at Harvard Medical School
and has 50 peer-reviewed publications to date. He served as Director of
the radiation oncology fellowship program at Brigham and Women’s
Hospital. He has won numerous awards, including the American Society of
Clinical Oncology Merit award, and is a co-investigator on a K18 award
from the National Institutes of Health.
Dr. Arvold was a Presidential Scholar and an NCAA Academic All-American
skier while completing his undergraduate education at Dartmouth College.
He was also a member of the U.S. Biathlon Team.
Publications
Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T,
Arvold ND, Ning M, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang
VL, Camidge DR, Contessa JN. Extended survival and prognostic factors
for patients with ALK rearranged NSCLC and brain metastasis. In press at
Journal of Clinical Oncology.
Han Z, Bondeson JC, Lewis JH, Mannarino EG, Friesen SA, Wagar MM, Balboni
TA, Alexander BM,
Arvold ND, Sher DJ, Hacker FL. Evaluation of initial setup accuracy and intra-fraction
motion for spine SBRT using stereotactic body frames. In press at
Practical Radiation Oncology.
Stockham AL,
Arvold ND. Central nervous system brachytherapy. In:
Brachytherapy: Applications and Techniques, Second Edition. Ed. Phillip Devlin. Philadelphia: Lippincott Williams & Wilkins,
in press 2015.
Aizer AA, Abedalthagafi M, Bi WL, Horvath MC,
Arvold ND, Al-Mefty O, Lee EQ, Nayak L, Rinne ML, Norden AD, Reardon DA, Wen PY,
Ligon KL, Ligon AH, Beroukhim R, Dunn IF, Santagata S, Alexander BM.
A prognostic cytogenetic scoring system to guide the adjuvant management
of patients with atypical meningioma. Neuro-Oncology 2015 Aug 30 (Epub ahead of print).
Aizer AA, Bi WL, Kandola MS, Lee EQ, Nayak L, Rinne ML, Norden AD, Beroukhim
R, Reardon DA, Wen PY, Al-Mefty O,
Arvold ND, Dunn IF, Alexander BM. Extent of resection and overall survival for patients
with atypical and malignant meningioma.
Cancer 2015 Aug 26 (Epub ahead of print).
Abou Al-Shaar H, Almefty KK, Abolfotoh M,
Arvold ND, Devlin PM, Reardon DA, Loeffler JS, Al-Mefty O. Brachytherapy in the
treatment of recurrent aggressive falcine meningiomas.
J Neurooncol 2015 Aug 8 (Epub ahead of print).
Liu Y, Alexander BM, Chen YH, Horvath MC, Aizer AA, Claus EB, Dunn IF,
Golby AJ, Johnson MD, Friesen S, Mannarino EG, Wagar M, Hacker FL,
Arvold ND. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial
stereotactic radiosurgery for 1-4 brain metastases.
J Neurooncol 2015 Jun 25 (Epub ahead of print).
Aizer AA, Du R, Wen PY,
Arvold ND. Radiotherapy and death from cerebrovascular disease in patients with
primary brain tumors.
J Neurooncol 2015 Jun 17 (Epub ahead of print).
Rahman R, Catalano P, Reardon DA, Norden AD, Wen PY, Lee EQ, Nayak L, Beroukhim
R, Dunn IF, Golby AJ, Johnson MD, Chiocca EA, Claus EB, Alexander BM,
Arvold ND. Incidence, risk factors, and reasons for hospitalization among glioblastoma
patients receiving chemoradiation.
J Neurooncol 2015 Jun 2 (Epub ahead of print).
Arvold ND*, Tanguturi SK*, Aizer AA, Wen PY, Reardon DA, Lee EQ, Nayak L, Christianson LW, Horvath
MC, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL, Alexander
BM. Hypofractionated versus standard radiotherapy with or without temozolomide
for older glioblastoma patients.
Int J Radiat Oncol Biol Phys 2015 Jun 1;92(2):384-389. (* co-first authors)
